1887

Abstract

Human monoclonal antibodies to rabies virus were established by Epstein-Barr virus infection of peripheral blood lymphocytes collected from a rabies- vaccinated donor, and fusion with a heteromyeloma line. Two human monoclonal antibodies, HUM1 and HUM2, both IgG2, reacted with the envelope glycoprotein of the rabies virus. The antibody HUM1 neutralized rabies virus (lyssavirus serotype 1) and Mokola virus (lyssavirus serotype 3), but did not neutralize European bat lyssavirus, suggesting that some common antigenicity exists between the glycoproteins of serotypes 1 and 3. In addition, this antibody neutralized a series of viruses resistant to neutralization by antibodies recognizing, in a murine system, anti genic sites I, II and III; however, it failed to neutralize viruses altered at site VI, indicating that human monoclonal antibody HUM1 is directed against antigenic site VI. The other human anti-glycoprotein antibody, HUM2, neutralized the European bat lyssavirus in addition to serotypes 1 and 3, but none of the resistant variant viruses altered at the sites mentioned above. A third human monoclonal antibody, HUM3 (IgM), was reactive with the internal nucleoprotein of the rabies virus. This antibody contained a murine light chain corresponding to the cytoplasmic murine chain not secreted in the heteromyeloma line. The potential use of monoclonal antibodies in post-exposure treatment of rabies is discussed.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-8-1689
1990-08-01
2022-08-10
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/8/JV0710081689.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-8-1689&mimeType=html&fmt=ahah

References

  1. Atanasiu P. 1978; Quantitative assay and potency test of antirabies serum and immunoglobulin. In Laboratory Techniques in Rabies, 2nd edn.. pp 314–318 Kaplan M. M., Koprowski H. Edited by Geneva: World Health Organization;
    [Google Scholar]
  2. Balthazard M., Bahmanyar M. 1955; Essai pratique du serum antirabique chez les mordus par des loups enrages. Bulletin of the World Health Organization 13:747–772
    [Google Scholar]
  3. Bouvet J. P., Pillot J. 1985; A new simple blot transfer method following Cellogel electrophoresis which preserves antibody activity : application to the analysis of monoclonal and oligoclonal fluids. Annales de l’Institut Pasteurjlmmunologie 136D:119–130
    [Google Scholar]
  4. Bunschoten H. 1989 The immune response to rabies virus idiotypes and regulation Ph. D. thesis University of Utrecht:
    [Google Scholar]
  5. Bunschoten H., Gore M., Claassen I. J. T. M., Uytdehaag F. G. C. M., Dietzschold B., Wunner W. H., Osterhaus A. D. M. E. 1989; Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. Journal of General Virology 70:291–298
    [Google Scholar]
  6. Celis E., Ou D., Dietzschold B., Koprowski H. 1988; Recognition of rabies and rabies-related viruses by T cells derived from human vaccine recipients. Journal of Virology 62:3128–3134
    [Google Scholar]
  7. Clark H. F., Wiktor T. J. 1972; Rabies virus. In Strains of Human Viruses pp 177–182 Majer M., Plotkin S. A. Edited by Basel: S. Karger;
    [Google Scholar]
  8. Dietzschold B., Wiktor T. J., Macfarlan R. I., Varrichio A. 1982; Antigenic structure of rabies virus glycoprotein: ordering and immunological characterization of the large CnBr cleavage fragments. Journal of Virology 44:595–602
    [Google Scholar]
  9. Dietzschold B., Lafon M., Wang H., Otvos L. Jr Celis E., Wunner W. H., Koprowski H. 1987; Localization and immunological characterization of antigenic domains of the rabies virus internal N and NS proteins. Virus Research 8:103–125
    [Google Scholar]
  10. Dietzschold B., Rupprecht C. E., Tollis M., Lafon M., Mattei J., Wiktor T. J., Koprowski H. 1988; Antigenic diversity of the glycoprotein and nucleocapsid proteins of rabies and rabies-related viruses: implications for epidemiology and control of rabies. Review of Infectious Diseases 10:S785–S798
    [Google Scholar]
  11. Dietzschold B., Gore M., Ertl H., Celis E., Otvos L. Jr Koprowski H. 1990; Analysis of protective immune mechanisms induced by rabies nucleoprotein. In Genetics and Pathogenicity of Negative Strand Viruses Mahy B. W. J., Kolakofsky D. Edited by Amsterdam: Elsevier; in press
    [Google Scholar]
  12. Flamand A., Wiktor T. J., Koprowski H. 1980; Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein. Journal of General Virology 48:105–109
    [Google Scholar]
  13. Foggin C. M. 1982; Atypical rabies virus in cats and a dog in Zimbabwe. Veterinary Record 110:338
    [Google Scholar]
  14. Köhler G., Milstein K. 1975; Continuous cultures of fused cells secreting antibody of predefined specificity. Nature; London: 256495–497
    [Google Scholar]
  15. Koprowski H., Wiktor T. J., Abelseth M. K. 1985; Crossreactivity and cross-protection: rabies variants and rabies-related viruses. In Rabies in the Tropics pp 30–39 Kuwert E., Merieux C., Koprowski H., Bögel K. Edited by Berlin: Springer-Verlag;
    [Google Scholar]
  16. Kozlor K., Roder J. C. 1981; Requirements for the establishment of high titred human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. Journal of Immunology 127:1275–1280
    [Google Scholar]
  17. Lafon M., Wiktor T. J., Macfarlan R.I. 1983a; Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. Journal of General Virology 64:843–851
    [Google Scholar]
  18. Lafon M., Ideler J., Wunner W. H. 1983b; Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies. Developments in Biological Standardization 57:219–225
    [Google Scholar]
  19. Lafon M., Herzog M., Sureau P. 1986; Human rabies vaccine induce neutralizing antibodies against the European bat rabies virus (Duvenhage). Lancet ii:515
    [Google Scholar]
  20. Libeau G., Lafon M. 1983; Production of monoclonal antibodies against the Pasteur virus (PV strain): problems and results. Develoments in Biological Standardization 57:213–218
    [Google Scholar]
  21. MacMorris F. A., Ruddle F. H. 1974; Expression of neuronal phenotypes in neuroblastoma cell hybrids. Developmental Biology 39:226–246
    [Google Scholar]
  22. Miller G., Shope T., Lisco L., Stih D., Lipman M. 1972; Epstein-Barr virus transformation, cytopathic changes on viral antigens in squirrel, monkey and marmoset leucocytes. Proceedings of the National Academy of Sciences U.S.A.: 69383–387
    [Google Scholar]
  23. Sato M., Maida N., Yoshida H., Urade M., Saito S., Miyazaki T., Shibata T., Watanabe M. 1977; Plaque formation of herpes virus hominidis type 2 and rubella virus in variants isolated from the colonies of BHK-21/WI-2 cells formed in soft agar. Archives of Virology 53:269–273
    [Google Scholar]
  24. Schneider L. G. 1982; A new case of bat-rabies virus in Germany. Rabies Bulletin of Europe 4:17
    [Google Scholar]
  25. Sikes R. K., Clearly W. F., Koprowski H., Wiktor T. J., Kaplan M. M. 1971; Effective protection of monkey against death by street virus by post-exposure administration of tissue-culture rabies vaccine. Bulletin of the World Health Organization 45:1–11
    [Google Scholar]
  26. Smith J. S., Yager P. A., Baer G. M. 1973; A rapid tissue culture test for determining rabies neutralising antibody. In Laboratory Techniques in Rabies, 2nd edn.. pp 354–357 Kaplan M. M., Koprowski H. Edited by Geneva: World Health Organization;
    [Google Scholar]
  27. Sokol F., Clark H. F. 1973; Phosphoproteins, structural components of rhabdoviruses. Virology 52:99–112
    [Google Scholar]
  28. Who Exvert Committee On Rabies 1984 Technical Report Series 70928–29
    [Google Scholar]
  29. Wiktor T. J. 1985; Is a special vaccine required against rabies related viruses and variants of rabies?. In Improvements in Rabies Post-exposure Treatment pp 9–13 Vodopija I., Nicholson K. G., Smerdel S., Bijok U. Edited by Zagreb: Institute of Public Health;
    [Google Scholar]
  30. Wiktor T. J., Koprowski H. 1978; Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants. Proceedings of the National Academy of Sciences U.S.A.: 753938–3942
    [Google Scholar]
  31. Wiktor T. J., Koprowski H. 1980; Antigenic variants of rabies viruses. Journal of Experimental Medicine 152:99–112
    [Google Scholar]
  32. Wiktor T. J., Macfarlan R. I., Foggin C. M., Koprowski H. 1984; Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Developments in Biological Standardization 57:199–211
    [Google Scholar]
  33. Wilde H., Chomchey P., Prakongsri S., Puyaratabandhu P. 1987; Safety of equine rabies immunoglobulin. Lancet ii:1275
    [Google Scholar]
  34. Wilde H., Chomchey P., Prakongsri S., Puyaratabandhu P., Chutivongue S. 1989; Adverse effects of equine rabies immune globulins. Vaccine 1:10–11
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-8-1689
Loading
/content/journal/jgv/10.1099/0022-1317-71-8-1689
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error